Rana McKay

Rana McKay is a Clinical Professor in the School of Medicine at the University of California, San Diego (UCSD), specializing in oncology with a focus on genitourinary cancers. Her research spans prostate cancer, renal cell carcinoma, and urologic oncology, with significant contributions to clinical trials, biomarker development, and precision medicine approaches.

Dr. McKay's research interests include prostate cancer therapeutics, particularly in metastatic castration-resistant prostate cancer (mCRPC), where she has led numerous clinical trials investigating novel treatments including androgen receptor targeting agents, PARP inhibitors, and immunotherapies. Her work extends to renal cell carcinoma, where she examines treatment sequencing, biomarker identification, and novel therapeutic combinations. She has made significant contributions to understanding health disparities in cancer outcomes, particularly among minority populations and cancer survivors.

Analysis of Dr. McKay's publications reveals a strong focus on translational research with direct clinical applications. Her work spans multiple phases of clinical development, from early biomarker discovery to phase III clinical trials. A notable trend is her investigation of genomic alterations in prostate cancer, particularly related to DNA repair pathways and their implications for targeted therapy. She also has significant contributions in the area of health disparities, examining how factors like race, ethnicity, and socioeconomic status impact cancer outcomes.

Dr. McKay has been actively involved in numerous multicenter clinical trials and consortia, collaborating with major cancer research groups internationally. Her extensive publication record demonstrates leadership in designing and implementing clinical research protocols that address critical gaps in genitourinary oncology.